Abstract
3'-Fluoro-3'-deoxythymidine (FLT) positron emission tomography (PET) has been proposed for imaging thymidylate synthase (TS) inhibition. Agents that target TS and shut down de novo synthesis of thymidine monophosphate increase the uptake and retention of FLT in vitro and in vivo because of a compensating increase in the salvage pathway. Increases in both thymidine kinase-1 (TK1) and the equilibrative nucleoside transporter hENT1 have been reported to underlie this effect. We examined whether the effects of one TS inhibitor, 5-fluorouracil (5FU), on FLT uptake require proliferating cells and whether the effects are limited to increasing TK1 activity. The effects of 5FU on FLT transport and metabolism, TK1 activity, and cell cycle progression were evaluated in the human tumor cell line, A549, maintained as either a proliferating or non-proliferating culture. There were dose-dependent increases in FLT uptake that peaked after a 10 μM 5FU exposure and then declined to baseline levels or below at higher doses in both proliferating and non-proliferating cultures. The dose-dependence for FLT uptake was mirrored by changes in TK1 activity. S phase fraction did not correlate with FLT uptake in proliferating cultures. Chemical inhibition...Continue Reading
References
May 25, 2002·Cancer Treatment Reviews·C AscheleS Monfardini
Jun 27, 2002·Biochimica Et Biophysica Acta·Debabrata BanerjeeJoseph R Bertino
Nov 19, 2002·The Biochemical Journal·Po-Yuan KeZee-Fen Chang
May 8, 2003·Journal of the National Cancer Institute·Paula WellsDavid R Newell
Apr 20, 2004·Nuclear Medicine and Biology·Jeffrey L SchwartzKenneth A Krohn
Oct 7, 2004·Nuclear Medicine and Biology·John R GriersonKenneth A Krohn
Nov 27, 2004·European Journal of Nuclear Medicine and Molecular Imaging·Lukas B BeenPhilip H Elsinga
Dec 21, 2004·Oncogene·Zhan XiaoHaiying Zhang
Jan 11, 2005·Current Medicinal Chemistry·W H Gmeiner
Aug 17, 2005·Genes & Development·Po-Yuan KeZee-Fen Chang
Mar 15, 2006·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Anthony F Shields
Mar 29, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Kawai YauEric Aboagye
Apr 19, 2006·Oncogene·H M R RobinsonD A F Gillespie
Sep 5, 2006·Cancer Research·Meg PerumalEric O Aboagye
Aug 2, 2008·Molecular Pharmacology·Robert J PaproskiCarol E Cass
Oct 1, 2009·Biochemical Pharmacology·Robert J PaproskiCarol E Cass
Oct 29, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laura M KennyEric O Aboagye
May 25, 2010·Advances in Medical Sciences·P CeppiG Scagliotti
Aug 20, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Robert J PaproskiCarol E Cass
Aug 20, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·David A PlotnikJeffrey L Schwartz
Aug 21, 2010·Biochemical Pharmacology·Seung Jin LeeDae Hyuk Moon
Oct 11, 2011·Nuclear Medicine and Biology·David A PlotnikJeffrey L Schwartz
Citations
Jun 1, 2013·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Lars StelterSteven M Larson
Apr 4, 2013·BMC Cancer·Mette Munk JensenAndreas Kjær
Oct 4, 2016·Drug Discovery Today·Sarah R MuddJohn D Beaver
Nov 1, 2016·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Sandra HeskampOtto C Boerman
Jun 26, 2018·Journal of Surgical Oncology·David A Mankoff, Sharyn I Katz
Aug 25, 2018·PloS One·Xiao ChenSharyn I Katz
Sep 23, 2016·Oncotarget·Xiao ChenSharyn I Katz
Nov 16, 2017·Oncotarget·Xiao ChenSharyn Katz
Oct 19, 2013·Oncology Letters·Masahiro MurakamiYuji Kuge
Dec 14, 2016·EJNMMI Research·Naoyuki UkonYuji Kuge
Dec 13, 2012·Oncology Reports·Eun Jung Lee, Seung Jin Lee